Antiviral Research publica un edició especial sobre els 25 anys del desenvolupament dels fàrmacs antiretrovirals

Més notícies Notícies
03/05/2010

Antiviral Research publica un edició especial sobre els 25 anys del desenvolupament dels fàrmacs antiretrovirals


La revista Antiviral Research, la publicació oficial de la Societat Internacional per la Recerca Antiviral (ISAR), ha editat un número especial sobre els 25 anys del desenvolupament dels fàrmacs antiretrovirals. Un dels editors de la revista ha estat José Esté, investigador d’IrsiCaixa i responsable del grup de recerca sobre Entrada Viral i Patogènesi. A continuació podeu disposar de les 24 publicacions que recull aquesta edició especial de la revista.

 

CONTINGUTS

  


Introduction

1. S. Broder

The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic

 

2. E. De Clercq

In search of a selective therapy of viral infections

 

3. J.A. Esté, T. Cihlar

Current status and challenges of antiretroviral research and therapy

 

Agents for the Treatment and Prophylaxis of HIV Infection

 

4. J. C. Martin, M.J.M. Hitchcock, E. De Clercq, W. H. Prusoff

Early nucleoside reverse transcriptase inhibitors for the treatment of HIV: A brief history of stavudine (D4T) and its comparison with other dideoxynucleosides

 

5. T. Cihlar, A. S. Ray

Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine

 

6. A.M.J. Wensing, N.M. van Maarseveen, M. Nijhuis

Fifteen years of HIV Protease Inhibitors: raising the barrier to resistance

 

7. M.-P. de Béthume

Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989–2009)

 

8. J.C. Tilton, R.W. Doms

Entry inhibitors in the treatment of HIV-1 infection

 

9. D.J. McColl, X. Chen

Strand transfer inhibitors of HIV-1 integrase: Bringing IN a new era of antiretroviral therapy

 

10. C.S. Adamson, E.O. Freed

Novel approaches to inhibiting HIV-1 replication

 

11. R.W. Buckheit Jr., K.M. Watson, K.M. Morrow, A.S. Ham

Development of topical microbicides to prevent the sexual transmission of HIV

 

Development and Use of Antiretrovirals

 

12. K.K.A. Van Rompay

Evaluation of antiretrovirals in animal models of HIV infection

 

13. L. Dickinson, S. Khoo, D. Back

Pharmacokinetics and drug-drug interactions of antiretrovirals: An update

 

14. V. Tozzi

Pharmacogenetics of antiretrovirals

 

15. T. Hawkins

Understanding and managing the adverse effects of antiretroviral therapy

 

16. L. Menéndez-Arias

Molecular basis of human immunodeficiency virus drug resistance: An update

 

17. L.K. Naeger, K.A. Struble, J.S. Murray, D.B. Birnkrant

Running a tightrope: Regulatory challenges in the development of antiretrovirals

 

Pathogenesis and Management of HIV Infection

 

18. A.R. Zolopa

The evolution of HIV treatment guidelines: Current state-of-the-art of ART

 

19. R. Paredes, B. Clotet

Clinical management of HIV-1 resistance

 

20. M. Penazzato, D. Donà, P.-S. Wool, O. Rampon, C. Giaquinto

Update on antiretroviral therapy in paediatrics

 

21. J. Fox, S. Fidler

Sexual transmission of HIV-1

 

22. V. Dahl, L. Josefsson, S. Palmer

HIV reservoirs, latency, and reactivation: Prospects for eradication

 

23. J.N. Blankson

Effector mechanism in HIV-1 infected elite controllers: Highly active immune responses?

 

24. V. Soriano, E. Vispo, P. Labarga, J. Medrano, P. Barreiro

Viral hepatitis and HIV co-infection

Subscriu-te a la newsletter

Back to Top
Irsi Caixa

Impulsat per:

Obra Social - Fundació 'La Caixa' Generalitat de Catalunya - Departament de Salut

 

HR Excellence in Research

Amb la col·laboració de: